Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.400
-0.050 (-2.04%)
Apr 28, 2026, 4:00 PM EDT - Market closed
CNTB Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2019 |
| Revenue | 0.06 | 26.03 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | -99.75% | - | - | - | - | Upgrade
|
| Gross Profit | 0.06 | 26.03 | - | - | - | Upgrade
|
| Selling, General & Admin | 20.34 | 17.43 | 16.05 | 20.81 | 19.01 | Upgrade
|
| Research & Development | 37.8 | 27.86 | 53 | 96.63 | 80.5 | Upgrade
|
| Other Operating Expenses | - | - | - | -1.08 | -1.85 | Upgrade
|
| Operating Expenses | 58.14 | 45.29 | 69.06 | 116.36 | 97.66 | Upgrade
|
| Operating Income | -58.07 | -19.25 | -69.06 | -116.36 | -97.66 | Upgrade
|
| Interest Expense | - | - | - | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | 2.27 | 4.45 | 5.22 | 1.81 | 0.17 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 1.47 | -0.52 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.52 | 2.59 | 1.85 | - | -103.98 | Upgrade
|
| EBT Excluding Unusual Items | -55.28 | -12.21 | -61.99 | -113.1 | -202 | Upgrade
|
| Asset Writedown | - | - | - | -4.7 | - | Upgrade
|
| Other Unusual Items | - | -3.2 | - | - | - | Upgrade
|
| Pretax Income | -55.28 | -15.41 | -61.99 | -117.79 | -202 | Upgrade
|
| Income Tax Expense | 0.2 | 0.22 | 0.12 | 0.3 | 0.27 | Upgrade
|
| Earnings From Continuing Operations | -55.48 | -15.63 | -62.11 | -118.09 | -202.27 | Upgrade
|
| Net Income | -55.48 | -15.63 | -62.11 | -118.09 | -202.27 | Upgrade
|
| Net Income to Common | -55.48 | -15.63 | -62.11 | -118.09 | -202.27 | Upgrade
|
| Shares Outstanding (Basic) | 56 | 55 | 55 | 55 | 52 | Upgrade
|
| Shares Outstanding (Diluted) | 56 | 55 | 55 | 55 | 52 | Upgrade
|
| Shares Change (YoY) | 0.81% | 0.27% | 0.04% | 5.50% | 205.31% | Upgrade
|
| EPS (Basic) | -1.00 | -0.28 | -1.13 | -2.15 | -3.88 | Upgrade
|
| EPS (Diluted) | -1.00 | -0.28 | -1.13 | -2.15 | -3.88 | Upgrade
|
| Free Cash Flow | -51.64 | -24.36 | -47.82 | -105.93 | -88.16 | Upgrade
|
| Free Cash Flow Per Share | -0.93 | -0.44 | -0.87 | -1.92 | -1.69 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | - | - | Upgrade
|
| Operating Margin | -90740.63% | -73.95% | - | - | - | Upgrade
|
| Profit Margin | -86687.50% | -60.03% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -80687.50% | -93.58% | - | - | - | Upgrade
|
| EBITDA | -57.37 | -18.59 | -68.34 | -115.63 | -97.17 | Upgrade
|
| EBITDA Margin | - | -71.42% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.7 | 0.66 | 0.72 | 0.73 | 0.49 | Upgrade
|
| EBIT | -58.07 | -19.25 | -69.06 | -116.36 | -97.66 | Upgrade
|
| EBIT Margin | - | -73.95% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.